Martin Empting at Department of Antiviral & Antivirulence Drugs (AVID) Helmholtz Institute for Pharmaceutical Rese - Research Interests, Publications & Academic Profile

Martin Empting

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

20%

Microbiology

40%

Antimicrobial Research

30%

Receptor Biology

20%

Chemical Biology

20%

Antiviral Research

20%

Gpcr

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle

Article Link

Year:

2023

Establishment of an In Bacterio Assay for the Assessment of Carbon Storage Regulator A (CsrA) Inhibitors

Article Link

Year:

2023

NMR Experiments Provide Insights into Ligand-Binding to the SARS-CoV-2 Spike Protein Receptor-Binding Domain

Article Link

Year:

2022

First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy

Article Link

Year:

2022

Transferring Microclusters of P. aeruginosa Biofilms to the Air-Liquid Interface of Bronchial Epithelial Cells for Repeated Deposition of Aerosolized Tobramycin

Article Link

Year:

2022

Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages

Article Link

Year:

2022

Modeling the Effect of Hydrophobicity on the Passive Permeation of Solutes across a Bacterial Model Membrane.

Article Link

Year:

2022

Phage display-based discovery of cyclic peptides against the broad spectrum bacterial anti-virulence target CsrA.

Article Link

Year:

2022

Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsR

Article Link

Year:

2021

Towards the sustainable discovery and development of new antibiotics.

Article Link

Year:

2021

KSHV-specific antivirals targeting the protein-DNA interaction of the latency-associated nuclear antigen.

Article Link

Year:

2021

Collaborators13

Mostafa M. Hamed

Helmholtz Institute for Pharmaceutical Research Saarland

GERMANY

Charlotte Uetrecht

Associate (W2) Professor

University of Siegen

GERMANY

Jiabin Huang

University Medical Center Hamburg-Eppendorf

GERMANY

Thomas Peters

Professor

University of Lübeck

GERMANY

Andrew White

Australian National University

AUSTRALIA

Anna Katharina Herta Hirsch

Full professor (W3)

Saarland University

GERMANY

Daniela Yildiz

Juniorprofessor

Saarland University

GERMANY

Thomas Durek

AUSTRALIA

Nicole Schneider-Daum

Helmholtz Institute for Pharmaceutical Research Saarland

GERMANY

Jean-Luc Pernodet

CNRS

FRANCE

Fabian Müller

Junior Professor

Saarland University

GERMANY

Helge B. Bode

Goethe University Frankfurt

GERMANY

Laura Piddock

University of Birmingham

UNITED KINGDOM

How do Indian students reach out?

Meet Kite AI